'Moderna Wins Case In Patent Dispute With Pfizer And BioNTech Over Covid Jab; Decision Is A Boon For The MRNA-Vaccine Maker In Its Legal Fight To Recoup Pandemic Profits From Rivals' - Financial Times
'Moderna Wins Case In Patent Dispute With Pfizer And BioNTech Over Covid Jab; Decision Is A Boon For The MRNA-Vaccine Maker In Its Legal Fight To Recoup Pandemic Profits From Rivals' - Financial Times
“Moderna在与辉瑞和BioNTech就Covid疫苗的专利纠纷中胜诉；该决定为这家mRNA疫苗制造商为从竞争对手那里收回大流行利润而进行的法律斗争中是一个福音”-《金融时报》
Moderna has won a case at the European Patent Office in its dispute with Pfizer and BioNTech over its Covid-19 vaccine, in a boon for the mRNA-vaccine maker in its ongoing legal fight to recoup pandemic profits from its rivals.
Moderna在欧洲专利局与辉瑞和BioNTech就其Covid-19疫苗发生的纠纷中胜诉，这对于这家mRNA疫苗生产商为从竞争对手那里收回大流行利润而进行的持续法律斗争带来了福音。
The decision by the EPO's Opposition Division on Thursday to uphold the validity of one of two disputed patents is a boost for Moderna, which has faced several setbacks in its legal battle over Pfizer and BioNTech's bestselling Comirnaty vaccine.
欧洲专利局反对部周四决定维持两项有争议专利之一的有效性，这对Moderna来说是一个推动力。Moderna在争夺辉瑞和BioNTech最畅销的Comirnaty疫苗的法律斗争中遇到了几次挫折。
"We are pleased to announce that the European Patent Office decided to maintain the validity of Moderna...
该公司告诉《金融时报》：“我们很高...
登录免费看全文
登录/注册